Concepedia

CC Turkel

CT

4

Publications

2.1K

Citations

4

H-Index

2010

Active since

Affiliations

Allergan (United States)(Current)

Swedish Medical Center

University of California, Irvine

Thomas Jefferson University

Albert Einstein College of Medicine

CC Turkel is an author at Allergan (United States) specializing in neurology, medicine, and pharmacology.

Top concepts

Publications per year

2010–2016

4

Publications

4

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

SK Aurora, DW Dodick, CC Turkel et al. · Cephalalgia · 2010 · 1K citations · Full text

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

HC Diener, DW Dodick, SK Aurora et al. · Cephalalgia · 2010 · 929 citations

, , +10

placebo-controlled phase of the PREEMPT 2 trial OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized,

HC Diener, DW Dodick, SK Aurora et al. · 2011 · 93 citations

, , +5

Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: effect on human mechanistic pain biomarkers and clinical pain

Lars Arendt‐Nielsen, Guangliang Jiang, Ronald E. DeGryse et al. · Scandinavian Journal of Rheumatology · 2016 · 60 citations

Rows per page

1–4 of 4